Carmustine
Who holds supplier records for Carmustine? 12 organisations hold a current record for Carmustine: an active US FDA Type II Drug Master File or a CEP. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), United States (2), Italy (1) and China (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Carmustine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/carmustine
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Carmustine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Ampac Fine ChemicalsUnited StatesCEPActive DMF 13169 · latest filing Sept 1998
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 32343 · latest filing Dec 2017
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 22905 · latest filing Jun 2009
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 33730 · latest filing Mar 2019
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 31156 · latest filing Dec 2016
- NERPHARMA SRLItalyCEP Company GMP cert on recordActive DMF 32922 · latest filing Jul 2018
- Vannsh Life Sciences Private LimitedIndiaCEPActive DMF 38686 · latest filing Dec 2023
- AGNO PHARMAActive DMF 30184 · latest filing Mar 2017
- CHEMPACIFIC CORPUnited StatesActive DMF 22637 · latest filing Mar 2009
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina Company GMP cert on recordActive DMF 32031 · latest filing Oct 2017
- JOHNSON MATTHEY PHARMACEUTICAL MATERIALSActive DMF 10290 · latest filing Jun 1993
- Natco PharmaIndia Company GMP cert on recordActive DMF 34547 · latest filing Mar 2020
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Carmustine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| VANNSH LIFE SCIENCES PRIVATE LIMITED Visakhapatnam | IN | CEP 2023-259 - Rev 00 Carmustine | Jul 2025 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2019-272 - Rev 02 Carmustine | Oct 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | CEP 2017-231 - Rev 04 Carmustine | Sept 2024 | Inspected Aug 2026 Slovakia |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2018-149 - Rev 03 Carmustine | Apr 2024 | — |
| NERPHARMA S.R.L. Nerviano | IT | R0-CEP 2021-212 - Rev 00 Carmustine | Aug 2023 | — |
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | R1-CEP 2011-192 - Rev 02 Carmustine | Apr 2023 | — |
| AMPAC FINE CHEMICALS Rancho Cordova | US | R1-CEP 2002-083 - Rev 02 Carmustine | Apr 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Carmustine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL513).
Chemical identity
- IUPAC name
- 1,3-bis(2-chloroethyl)-1-nitrosourea
- Canonical SMILES
- C(CCl)NC(=O)N(CCCl)N=O
- InChIKey
- DLGOEMSEDOSKAD-UHFFFAOYSA-N
- Synonyms
- BCNU, Becenun, Bicnu, Bischloroethyl nitrosourea, Camustine, Carmubris, Carmustina, Carmustine, Carmustine medac (previously carmustine obvius), Carmustine obvius, DTI-015, FDA-0345
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Alkylating Drug
- Mechanism of action
- Alkylating Activity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Carmustine?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Carmustine: Ampac Fine Chemicals (United States), APITORIA PHARMA PRIVATE LTD (India), Emcure Pharmaceuticals Limited (India), Intas Pharmaceuticals Ltd. (India), MSN Laboratories Private Limited (India), NERPHARMA SRL (Italy), Vannsh Life Sciences Private Limited (India) and AGNO PHARMA, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Carmustine Drug Master Files are active?
Ampac Fine Chemicals (DMF 13169), APITORIA PHARMA PRIVATE LTD (DMF 32343), Emcure Pharmaceuticals Limited (DMF 22905), Intas Pharmaceuticals Ltd. (DMF 33730), MSN Laboratories Private Limited (DMF 31156), NERPHARMA SRL (DMF 32922), Vannsh Life Sciences Private Limited (DMF 38686) and AGNO PHARMA (DMF 30184) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Carmustine have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Carmustine on the EDQM register, including VANNSH LIFE SCIENCES PRIVATE LIMITED Visakhapatnam (IN), INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN), MSN LABORATORIES PRIVATE LIMITED Kardanur Village (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), NERPHARMA S.R.L. Nerviano (IT) and EMCURE PHARMACEUTICALS LIMITED Pune (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Carmustine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Carmustine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.